Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 34-05 / SWOG 0230 (POEMS) 

Phase III of LHRH analog administration during chemotherapy to reduce ovarian failure following chemotherapy in early stage, hormone-receptor breast cancer

Prevention Of Early Menopause Study - POEMS

DESIGN

please click on the picture to see a larger version

Note: Participation in an adjuvant treatment trial does not, in general, exclude patients from POEMS.
If you would like to register patients from IBCSG 22-00 also into POEMS, those randomized into Arm A of IBCSG 22-00 would be eligible. Only patients randomized to the maintenance therapy arm would not be eligible for POEMS. Patients could, therefore, only participate in both studies if, following randomization to the standard arm, a one week delay before starting chemotherapy (which is required if randomized to the intervention arm on POEMS) is permissible.

Results & Publications


Presentations

Study Chairs
IBCSG: Dr. Kelly-Anne Phillips - Melbourne, Australia
SWOG: Dr. Halle C. F. Moore - Cleveland, USA

Statistician
Prof. RIchard Gelber

Trial Coordinators
Ann Lange, Emma Macdonald
Frontier Science (Scotland) Ltd.
Grampian View
Kincraig, Kingussie
PH21 1NA
Phone: +44 1540 651 000
Fax: +44 1540 651 007
Email: s0230@frontier-science.co.uk

Date of Activation
March 15, 2006

Targeted Accrual
416 patients

Results Publications Results & Publications


News

01.10.2014:
Benefiz-Gala mit Anton Mosimann Mittwoch 1. Oktober 2014 18.30 Uhr AURA, Bleicherweg 5, 8001 Zürich

11.09.2014:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 21st and 22nd, 2015 in

11.09.2014:
Breast Cancer Conference BCC 2015 18 - 21 March 2015 / Vienna / Austria  

All News

 
  Print